Dermatology News & Research

Latest in News & Research

DRAFT: CSS STYLES FOR CKEDITOR

This is an internal article/document to show/test the formatting of css for different CKEditor tags.

| Invalid date

How Effective is Sirolimus for Slow-Flow Vascular Malformations in Children?

Sirolimus does not impact volume changes detected on MRI scans, but does reduce pain, oozing, bleeding
This is another test bullet to preview wysiwyg...

By Dermsquared Editorial Team | February 16, 2024

Guidelines Issued for Gene Expression Profiling in Cutaneous Melanoma

GEP results can improve prognostic assessment for patients with tumors with uncertainty about adequacy of microstaging

By Dermsquared Editorial Team | December 14, 2023

mux test

testing embedded mux video

By test | October 19, 2023

Important Update

Winter Clinical Hawaii and Maui Wildfires

By Dermsquared Editorial Team | August 14, 2023

Does Vitamin D Supplementation Impact Psoriasis Severity?

No difference seen in change in PASI score, Physician Global Assessment score, self-administered PASI, Dermatology Life Quality Index

By Dermsquared Editorial Team | April 05, 2023

Risk for Melanoma Reduced for Individuals With Atopy

Fewer cases of melanoma, lower investigator-estimated risk class of skin cancer observed in atopic versus nonatopic individuals

By Elana Gotkine (HealthDay News) | March 31, 2023

AAD: Long-Term Efficacy Seen for Baricitinib in Alopecia Areata

39.1 percent of baricitinib 4-mg-treated patients with SALT score > 20 at week 52 achieved SALT score ≤ 20 by week 104

By Dermsquared Editorial Team | March 29, 2023

AAD: Nemolizumab Beneficial for Patients With Prurigo Nodularis

Improvement seen in primary and key secondary end points, including peak pruritus numerical rating scale, sleep disturbance

By Dermsquared Editorial Team | March 29, 2023

Promising Results Seen for Bimekizumab in Hidradenitis Suppurativa

Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50

By Elana Gotkine (HealthDay News) | March 29, 2023

Long-Term Improvement Seen With Ruxolitinib in Vitiligo

Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104

By Elana Gotkine (HealthDay News) | March 28, 2023

Risk for Skin Cancer Higher for Adults With Atopic Dermatitis

Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis

By Elana Gotkine (HealthDay News) | March 27, 2023

Topical Lovastatin Aids Disseminated Superficial Actinic Porokeratosis

Disease severity decreased by about 50 percent in the lovastatin-cholesterol and lovastatin-alone treatment groups

By Dermsquared Editorial Team | March 22, 2023

Hispanic Patients More Likely to Have Melanoma Diagnosed at Stage IV

Significant differences seen for insurance status, income, education, Charlson-Deyo score, stage for Hispanic, White patients

By Dermsquared Editorial Team | March 22, 2023

Smoking Independently Tied to Higher Risk for Psoriasis

However, based on genetic analysis, smoking may not be a causal factor of psoriasis

By Lori Solomon (HealthDay News) | March 21, 2023

Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients

No difference seen in keratinocyte cancers or actinic keratoses for organ-transplant recipients receiving oral nicotinamide or placebo

By Elana Gotkine (HealthDay News) | March 17, 2023

Can AI Tool Improve Quality of Patient-Submitted Images of Skin Disease?

Patient use of machine learning algorithm led to reduction in number of patients with poor-quality images

By Dermsquared Editorial Team | March 15, 2023

No Benefit Seen for Plasmapheresis First After Corticosteroids for SJS/TEN

Medical costs, LOS higher with plasmapheresis first versus intravenous immunoglobulin first for Stevens-Johnson syndrome and toxic epidermal necrolysis

By Dermsquared Editorial Team | March 15, 2023

Hair Regrowth Seen in Alopecia With Methotrexate Prednisone

About 31 percent of patients with recalcitrant alopecia areata totalis or universalis had complete hair regrowth

By Elana Gotkine (HealthDay News) | March 15, 2023

Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma

Event-free survival longer for those receiving neoadjuvant and adjuvant pembrolizumab versus adjuvant pembrolizumab only

By Physician's Briefing Staff | March 10, 2023

Microneedling, 5FU, Excimer Promising for Nonsegmental Vitiligo

Combination of 5FU after microneedling and excimer more suitable for localized, focal vitiligo

By Dermsquared Editorial Team | March 08, 2023

Is Paroxetine Efficacious, Safe for Erythema of Rosacea?

Significantly greater proportion of patients achieved Clinical Erythema Assessment success with paroxetine versus placebo

By Dermsquared Editorial Team | March 08, 2023

Most Patients Like Having Access to Dermatology Clinic Notes

Concerns were few and included not understanding notes or abbreviations

By Lori Solomon (HealthDay News) | March 08, 2023

Burden of Alopecia Areata Significant in the United States

Standardized prevalence highest in those aged 30 to 39, 40 to 49 years; Asians, Blacks, Hispanic/Latinos have increased prevalence ratios

By Elana Gotkine (HealthDay News) | March 06, 2023

24 of 523